Thrive Tribe Raises $240,554 via 318 Million Shares at 25% Discount
Thrive Tribe Technologies has completed a $240,554 capital raise through a discounted share placement, aiming to bolster its working capital. The placement involved issuing over 318 million shares at a 25% discount, with Clee Capital acting as lead manager.
- Raised $240,554 via placement of 318.6 million shares
- Shares issued at 25% discount to 15-day VWAP
- Funds allocated to general working capital and placement costs
- Clee Capital received 6% fee plus 32 million options pending shareholder approval
- Placement shares issued under ASX Listing Rules 7.1 and 7.1A
Capital Raise Details
Thrive Tribe Technologies Limited (ASX:1TT), a company focused on digital health and wellness platforms, has successfully completed a capital raise through a placement of 318,615,000 ordinary shares. The placement raised approximately $240,554 at a price of $0.000755 per share, representing a 25% discount to the volume weighted average price over the previous 15 days. This discount is a common feature in placements designed to attract sophisticated and professional investors quickly.
Use of Funds and Strategic Implications
The funds raised will be directed towards general working capital needs and covering the costs associated with the placement itself. While the amount raised is modest, it provides the company with additional liquidity to support ongoing operations and potentially invest in the further development of its core technology platform, Kumu. Kumu aims to connect individuals and businesses in the health and wellness sector, leveraging data-driven insights to foster engagement.
Role of Clee Capital and Shareholder Considerations
Clee Capital Pty Ltd acted as the lead manager for the placement, earning a 6% fee plus GST on the funds raised. Additionally, Clee Capital is set to receive 32 million options exercisable at $0.003 each, with a three-year expiry. However, these options are subject to shareholder approval at a forthcoming meeting, introducing an element of uncertainty regarding their final issuance. This arrangement aligns the interests of the lead manager with the company’s future performance but will require investor scrutiny.
Regulatory Compliance and Market Impact
The placement shares are being issued under ASX Listing Rules 7.1 and 7.1A, which govern the issuance of new shares without prior shareholder approval up to certain limits. This ensures compliance with regulatory frameworks while enabling the company to raise capital efficiently. Market reaction to such placements can vary, often depending on the perceived use of funds and the discount applied. Investors will be watching closely to see how Thrive Tribe leverages this capital to advance its strategic goals.
Bottom Line?
Thrive Tribe’s latest capital raise provides a modest boost but leaves investors eager for clarity on how the funds will accelerate growth.
Questions in the middle?
- How will Thrive Tribe deploy the new capital to drive growth in its Kumu platform?
- Will shareholders approve the issuance of options to Clee Capital, and what impact might this have on dilution?
- How will the market respond to the 25% discount and the company’s ongoing funding strategy?
